European Union Clinical Trials Register

In this Register, you are able to: •view the description of phase II to phase IV adult clinical trials where the investigator sites are in the EU/EEA; •view the description of any paediatric clinical trial with investigator sites in the EU/EEA; •view the description of any paediatric clinical trial that is sponsored by a marketing authorisation holder and involves the use of a medicinal product covered by an EU marketing authorisation in the paediatric population including trials conducted outside the EU / EEA; •view the description of any trials which form part of an agreed paediatric investigation plan (PIP) including those where the investigator sites are outside the EU/EEA; •view the summary results of the the clinical trials mentioned above; •view the summary results (with a reduced set of data fields) of paediatric trials completed by 26 January 2007 covered by an EU marketing authorisation; •download up to 50 results (per request) in a text file (.txt).

The details in the protocol related information include: •the design of the trial; •the sponsor; •the investigational medicine (trade name or active substance); •the therapeutic areas; •the status (authorised, ongoing or complete).

The details of the information of the summary results for a trial include: •the summary results in the form of datasets including: •trial information; •subject disposition; •baseline characteristics; •endpoints; •adverse events; •additional information; • summary attachment(s).

What is not available?

The EU Clinical Trials Register does not: •provide information on non-interventional clinical trials of medicines (observational studies on authorised medicines); •provide information on clinical trials for surgical procedures, medical devices or psychotherapeutic procedures;
•provide access to authorisation documents from national medicines regulators or the opinion documents from ethics committees; •provide information on clinical trials where all of the investigator sites are outside of the EU/EEA, except for trials that formed part of an agreed (PIP); •manage the process for joining a clinical trial published on the website; •provide navigation and web content in languages other than English.